Kynurenic acid levels ae elevated in the cerebrospinal fluid of patients with schizophrenia

Kynurenic acid is an endogenous glutamate antagonist with a preferential action at the glycine-site of the N-methyl D-aspartate-receptor. Mounting evidence indicate that the compound is significantly involved in basal neurophysiological processes in the brain. In the present investigation, cerebrosp...

Full description

Saved in:
Bibliographic Details
Published inNeuroscience letters Vol. 313; no. 1-2; p. 96
Main Authors Erhardt, Sophie, Blennow, Kaj, Nordin, Conny, Skogh, Elisabeth, Lindström, Leif, Engberg, Göran
Format Journal Article
LanguageEnglish
Published 02.11.2001
Subjects
MEDICIN
MEDICINE
Online AccessGet full text

Cover

More Information
Summary:Kynurenic acid is an endogenous glutamate antagonist with a preferential action at the glycine-site of the N-methyl D-aspartate-receptor. Mounting evidence indicate that the compound is significantly involved in basal neurophysiological processes in the brain. In the present investigation, cerebrospinal fluid (CSF) level of kynurenic acid was analyzed in 28 male schizophrenic patients and 17 male healthy controls by means of high pressure liquid chromatography and fluorescence detection. Schizophrenic patients showed elevated CSF levels of kynurenic acid (1.67 ▒ 0.27 nM) compared to the control group (0.97 ▒ 0.07 nM). Furthermore, CSF levels of kynurenic acid in schizophrenic patients were also found to correlate with age. The present finding is indicative of a contribution of kynurenic acid in the pathogenesis of schizophrenia. ⌐ 2001 Elsevier Science Ireland Ltd. All rights reserved.
ISSN:1872-7972
0304-3940
DOI:10.1016/S0304-3940(01)02242-X